Welcome to LookChem.com Sign In|Join Free

CAS

  • or

135080-29-4

5-Isoxazolecarboxylic acid, 3-ethoxy-(9CI) is a chemical compound with the molecular formula C6H7NO4. It is a derivative of isoxazole, a heterocyclic compound consisting of a five-membered ring with one oxygen and two nitrogen atoms. The 3-ethoxy group in this compound is an ethyl ether substituent attached to the 3-position of the isoxazole ring. This specific chemical is primarily used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly those containing the isoxazole moiety. Its unique structure and reactivity make it a valuable building block in the development of new compounds with potential therapeutic or pesticidal properties.

135080-29-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 135080-29-4 Structure

  • Basic information

    1. Product Name: 5-Isoxazolecarboxylicacid,3-ethoxy-(9CI)
    2. Synonyms: 5-Isoxazolecarboxylicacid,3-ethoxy-(9CI);3-Ethoxy-isoxazole-5-carboxylic acid
    3. CAS NO:135080-29-4
    4. Molecular Formula: C6H7NO4
    5. Molecular Weight: 157.12408
    6. EINECS: N/A
    7. Product Categories: OXAZOLE
    8. Mol File: 135080-29-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 346.2±22.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.326±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 2.19±0.10(Predicted)
    10. CAS DataBase Reference: 5-Isoxazolecarboxylicacid,3-ethoxy-(9CI)(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-Isoxazolecarboxylicacid,3-ethoxy-(9CI)(135080-29-4)
    12. EPA Substance Registry System: 5-Isoxazolecarboxylicacid,3-ethoxy-(9CI)(135080-29-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 135080-29-4(Hazardous Substances Data)

135080-29-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 135080-29-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,0,8 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 135080-29:
(8*1)+(7*3)+(6*5)+(5*0)+(4*8)+(3*0)+(2*2)+(1*9)=104
104 % 10 = 4
So 135080-29-4 is a valid CAS Registry Number.

135080-29-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Ethoxyisoxazole-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 3-ethoxy-5-isoxazolecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:135080-29-4 SDS

135080-29-4Upstream product

135080-29-4Downstream Products

135080-29-4Relevant articles and documents

Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands

-

, (2008/06/13)

Substituted 1,2,4-Triazolo[3,4-A]phthalazine derivatives are GABA Alpha 5 ligands and are represented by the formula

3-SUBSTITUTED-2-OXINDOLE DERIVATIVES

-

, (2008/06/13)

This invention relates to novel 3-substituted-2-oxindole derivatives which are inhibitors of prostaglandin H 2 synthase, 5-lipoxygenase and interleukin-1 biosynthesis. The compounds of the invention are useful as inhibitors of prostaglandin H 2 synthase and interleukin-1 biosynthesis, per se, and as analgesic, antiinflammatory and antiarthritic agents in the treatment of chronic inflammatory diseases. This invention also relates to pharmaceutical compositions comprising said 3-substituted-2-oxindole derivatives; to methods of inhibiting prostaglandin H 2 synthase and biosynthesis of interleukin-1; and to treating chronic inflammatory diseases in a mammal with said compounds. Further, this invention relates to certain novel carboxylic acids useful as intermediates in the preparation of the 3-substituted-2-oxindole derivatives of this invention and to a process for the preparation of the 3-substituted-2-oxindole derivatives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 135080-29-4